← Back to Search

ED-TREAT for Eating Disorders

N/A

Waitlist Available

Led By Ambrose H. Wong, (203) 737-2489

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Adult (age≥18) patients presenting to the YNHH ED during the pilot trial period

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Study Summary

This trial will test a new treatment for eating disorders that is acceptable to patients, delivers the intended treatment, and is feasible to implement.

Who is the study for?

This trial is for adults over 18 who might be at risk of psychomotor agitation or behavioral disorders. Participants should not need physical restraints upon arrival, must be alert and calm, speak English well enough to converse, and can verbally agree to join the study.Check my eligibility

What is being tested?

The ED-TREAT approach is being tested against usual care methods to see if it's acceptable, can be followed as intended (fidelity), and works well in practice (feasibility) for early detection and treatment of agitation.See study design

What are the potential side effects?

Since this trial focuses on a procedural intervention rather than a drug, specific side effects are not listed. However, there may be general risks associated with changes in management of agitation such as increased anxiety or discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years or older and went to the YNHH ED during the trial period.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Proportion of visits adherent to protocol

Secondary outcome measures

System usability scale

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: ED-TREATExperimental Treatment1 Intervention

EHR-embedded clinical decision support (CDS) tool designed to overcome the challenges to risk assessment and suggest pre-emptive use of behavioral techniques in the emergency setting.

Group II: Usual CareActive Control1 Intervention

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor

1,847 Previous Clinical Trials

2,736,502 Total Patients Enrolled

1 Trials studying Psychomotor Agitation

24 Patients Enrolled for Psychomotor Agitation

National Institute of Mental Health (NIMH)NIH

2,782 Previous Clinical Trials

2,689,081 Total Patients Enrolled

4 Trials studying Psychomotor Agitation

280 Patients Enrolled for Psychomotor Agitation

Ambrose H. Wong, (203) 737-2489Principal InvestigatorYale University

Media Library

ED-TREAT Clinical Trial Eligibility Overview. Trial Name: NCT04959279 — N/A

ED-TREAT 2023 Treatment Timeline for Medical Study. Trial Name: NCT04959279 — N/A

Psychomotor Agitation Research Study Groups: ED-TREAT, Usual Care

Psychomotor Agitation Clinical Trial 2023: ED-TREAT Highlights & Side Effects. Trial Name: NCT04959279 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are enrollment slots still available for this research program?

"The current listings on clinicaltrials.gov demonstrate that this medical research is not actively enrolling at the moment; however, it was initially posted in December 2024 and updated last August 2022. Fortunately, there are currently 144 other trials seeking participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

ED-TREAT (Early Detection and Treatment to Reduce Events With Agitation Tool) Compared to Usual Care

2024. "ED-TREAT (Early Detection and Treatment to Reduce Events With Agitation Tool) Compared to Usual Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04959279.